Shionogi Of Japan To Buy China’s C&O For $184.22 Million
This article was originally published in PharmAsia News
Executive Summary
Japan's Shionogi said it plans to buy China's C&O Pharmaceutical Technology for about $184.22 million to increase its presence in the China market. The purchase agreement includes buying the 24.17% stake of Leo Star Development, a Chinese investment company